Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome
Condition(s):Leukemia; Myelodysplastic SyndromesLast Updated:July 17, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Leukemia; Myelodysplastic SyndromesLast Updated:July 17, 2012Completed
Condition(s):Acute Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic SyndromeLast Updated:April 22, 2015Terminated
Condition(s):Refractory LeukemiaLast Updated:November 18, 2023Recruiting
Condition(s):Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia (CMML); MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable); Hematopoietic Stem Cell TransplantLast Updated:January 26, 2024Recruiting
Condition(s):Myelodysplastic Syndrome; LeukemiaLast Updated:May 8, 2015Completed
Condition(s):Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative DiseasesLast Updated:May 24, 2017Terminated
Condition(s):Hematologic Neoplasms; Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Multiple MyelomaLast Updated:March 3, 2016Completed
Condition(s):Acute Myeloid Leukemia; Adult Acute Megakaryoblastic Leukemia; Adult Acute Monoblastic Leukemia; Adult Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With Maturation; Adult Acute Myeloid Leukemia With Minimal Differentiation; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL; Adult Acute Myeloid Leukemia Without Maturation; Adult Acute Myelomonocytic Leukemia; Adult Erythroleukemia; Adult Pure Erythroid Leukemia; Alkylating Agent-Related Acute Myeloid Leukemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Recurrent Adult Acute Myeloid Leukemia; Secondary Myelodysplastic SyndromeLast Updated:August 4, 2022Completed
Condition(s):Severe Aplastic AnemiaLast Updated:November 18, 2023Recruiting
Condition(s):Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative DiseasesLast Updated:October 1, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.